Loading…
Korsana Biosciences, Inc.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in KRSA.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| OMEROmeros Corp | $19.43 | 11.8x | — | — | — | $1.41B |
| PIIIP3 Health Partners Inc. | $6.94 | — | — | — | -192.58% | $1.41B |
| CERTCertara, Inc. | $9.13 | — | 1.4x | — | -2.21% | $1.39B |
| CNMDCONMED Corp | $46.48 | 25.4x |
Korsana Biosciences, Inc., a biotechnology company that discovers and develops novel therapies for neurodegenerative diseases. The company was incorporated in 2024 and is based in Waltham, Massachusetts.
Company description provided by Yahoo Finance.
| 1.3x |
| 1.72% |
| 5.53% |
| $1.39B |
| DRTSAlpha Tau Medical Ltd. | $15.04 | — | 31.5x | — | -141.68% | $1.39B |
| AAPGAscentage Pharma Group International | $14.89 | — | 16.8x | — | -236.63% | $1.39B |